AeroVironment Just Delivered Historic Results. Wall Street Says It's a Buy

AeroVironment's fiscal 2027 Q1 revenue rose 6% to a record $480.5 million, beating $456.1 million consensus, while adjusted EPS surged 84% to $0.59 versus $0.25 expected. Autonomous systems revenue grew 21% to $346 million, bookings jumped 71% to $683 million, and funded backlog increased 37% year over year to a record $1.5 billion. Management maintained FY2027 revenue guidance of $2.125 billion-$2.225 billion, although midpoint adjusted EPS guidance of $3.16 implies a 4% decline due to planned capacity-expansion depreciation; recent $50 million LOCUST and $464.8 million Army laser contracts support the growth outlook.

Analysis

AVAV's setup has shifted from a pure drone-growth multiple to an execution-and-de-risking story. The earnings beat and backlog growth support near-term revenue visibility, but maintained full-year guidance implies management is not yet willing to underwrite accelerated conversion of awards into revenue; the market should therefore value the quarter as evidence of demand rather than a clean earnings inflection. The key 1-3 month catalyst is whether the next report raises revenue or margin guidance, particularly as capacity investment begins to burden reported EPS.

The more differentiated read is that counter-UAS and directed-energy production awards can improve AVAV's strategic value but may initially dilute margins and increase working-capital intensity versus its legacy small-UAS business. International demand broadens the addressable market, yet export approvals, customer acceptance testing, and milestone-based funding create a longer and less linear revenue cycle. Lockheed Martin (LMT), Northrop Grumman (NOC), RTX and Kratos (KTOS) remain better-capitalized alternatives if defense budgets favor integrated air-defense architectures rather than stand-alone systems.

Consensus appears to focus on the sharp valuation reset, but 32x next-year earnings still requires sustained high-teens growth and successful absorption of incremental depreciation. The prior financial restatement and contract loss should leave a higher credibility discount until at least two clean reporting periods demonstrate cash conversion, stable program margins, and no further control issues. A post-results rally is investable only if it is supported by funded backlog conversion rather than analyst-target revisions.

Over 6-18 months, AVAV can earn a premium if counter-drone procurement shifts from pilot programs to repeatable multi-year programs of record. Conversely, a continuing mix shift toward lower-margin hardware, delayed appropriations, or any reduction in unfunded-backlog conversion would expose the stock to multiple compression despite strong bookings.

Key Decisions for Investors

• Initiate a starter long AVAV only on confirmation that the post-earnings move holds for 3-5 sessions with above-average volume; target a 15-25% re-rating over 6-12 months if management raises FY revenue guidance and operating-margin trajectory. Limit risk with a 10-12% stop or reduce if the next quarter shows backlog growth without operating-cash-flow improvement.
• Prefer a relative-value pair: long AVAV / short KTOS in equal beta-adjusted dollars for 3-6 months. AVAV has the more visible funded-order conversion opportunity, while KTOS is more exposed to valuation sensitivity around autonomous-defense expectations; exit if AVAV's AxS growth falls below low teens or KTOS secures a comparable program-of-record award.
• Do not add aggressively ahead of the next earnings release without disclosure of operating cash flow, inventory/receivables growth, and segment margins. Set an alert for a cut to EPS guidance beyond the stated capacity-expansion depreciation effect; that would indicate execution pressure rather than deliberate investment.
• For diversified defense exposure, retain LMT/RTX rather than chase AVAV after a sharp gap higher. These primes are likely beneficiaries if counter-UAS spending scales through integrated command-and-control and interceptor procurement, and provide downside resilience if AVAV's individual programs slip.